Glucose sensing in pancreatic β-cells: A model for the study of other glucose-regulated cells in gut, pancreas, and hypothalamus

Diabetes

Volumn 50, Issue 1, 2001, Pages 1-11

  Schuit, Frans C ^a   Huypens, Peter ^a   Heimberg, Harry ^a   Pipeleers, Daniel G ^a  

^a DIABETES RESEARCH CENTER   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; POTASSIUM CHANNEL;

CELL FUNCTION; CONTROL SYSTEM; ENDOCRINE CELL; ENZYME REGULATION; GLUCOSE HOMEOSTASIS; HORMONAL REGULATION; HUMAN; HYPOTHALAMUS; NERVE CELL; NONHUMAN; NUTRIENT; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; REVIEW; SENSOR; SIGNAL TRANSDUCTION;

EID: 0035157768     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.50.1.1     Document Type: Review

References (117)

1. Pancreatic β-cell glucokinase: Closing the gap between theoretical concepts and experimental realities
2. Signal transduction mechanisms in nutrient-induced insulin secretion
3. Multisite control of insulin release by glucose
4. Metabolic coupling factors in pancreatic β-cell signal transduction
5. Heterogeneity in pancreatic β-cell population
6. Glucagon-like peptides
7. Central nervous system control of food intake
8. Cloning and functional expression in bacteria of a novel glucose transporter present in liver, intestine, kidney, and β-pancreatic islet cells
9. Cellular origin of hexokinase in pancreatic islets
10. Metabolic fate of glucose in purified islet cells: Glucose-regulated anaplerosis in β-cells
11. The changes in adenine nucleotides measured in glucose-stimulated rodent islets occur in β-cells but not in α-cells, and are also observed in human islets
12. Energy metabolism in the perfused, arrested rabbit heart
13. Energetic and morphological plasticity of C6 glioma cells grown on 3-D support: Effect of transient glutamine deprivation
14. Dual mechanisms for glucose 6-phosphate inhibition of human brain hexokinase
15. An alternate promoter in the glucokinase gene is active in the pancreatic β-cell
16. Differential expression and regulation of the glucokinase gene in liver and islets of Langerhans
17. Transcriptional induction of glucokinase gene by insulin in cultured liver cells and its repression by the glucagon-cAMP system
18. Pancreatic hormone receptors on islet cells
19. Glucagon receptors on human islet cells contribute to glucose competence of insulin release
20. Tissue-specific knockout of the insulin receptor in pancreatic β-cells creates an insulin secretory defect similar to that in type 2 diabetes
21. Interplay of nutrients and hormones in the regulation of insulin release
22. Effects of glucose on insulin secretion, glucokinase activity, and transgene expression in transgenic mouse islets containing an upstream glucokinase promoter-human growth hormone fusion gene
23. Metabolic regulation, activity state, and intracellular binding of glucokinase in insulin-secreting cells
24. Modulation of glucose responsiveness of insulinoma β-cells by graded overexpression of glucokinase
25. Acute glucose intolerance in insulinoma cells with unbalanced overexpression of glucokinase
26. The regulatory protein of glucokinase
27. The regulatory protein of glucokinase binds to the hepatocyte matrix, but, unlike glucokinase, does not translocate during substrate stimulation
28. Nuclear import of hepatic glucokinase depends upon glucokinase regulatory protein, whereas export is due to a nuclear export signal sequence in glucokinase
29. Translocation of glucokinase in pancreatic β-cells during acute and chronic hyperglycemia
30. Heterogeneity in glucose sensitivity among pancreatic β-cells is correlated to differences in glucose phosphorylation rather than glucose transport
31. Primary pancreatic β-cell secretory defect caused by mutations in glucokinase gene in kindreds of maturity onset diabetes of the young
32. Transgenic knockouts reveal a critical requirement for pancreatic β-cell glucokinase in maintaining glucose homeostasis
33. Dual roles for glucokinase in glucose homeostasis as determined by liver and pancreatic β-cell-specific gene knock-outs using Cre recombinase
34. Low lactate dehydrogenase and high mitochondrial glycerol phosphate dehydrogenase in pancreatic β-cells: Potential role in nutrient sensing
35. Lactate production in pancreatic islets
36. β-cell mitochondria in the regulation of insulin secretion: A new culprit in type II diabetes
37. Molecular biology of adenosine triphosphate-sensitive potassium channels
38. Molecular determinants of KATP channel inhibition by ATP
39. Adenosine diphosphate as an intracellular regulator of insulin secretion
40. Stimulus-secretion coupling in pancreatic β-cells
41. + channels in mouse B cells
42. +-ATP channel-independent pathway of regulation of insulin secretion by glucose: In search of the underlying mechanism
43. Feasibility of a mitochondrial pyruvate malate shuttle in pancreatic islets: Further implications of cytosolic NADPH in insulin secretion
44. Evidence for an anaplerotic/malonyl-CoA pathway in pancreatic β-cell nutrient signaling
45. Mitochondrial glutamate acts as a messenger in glucose-induced insulin exocytosis
46. Differences in glucose handling by pancreatic A- and B-cells
47. Calcium-independent potentiation of insulin release by cyclic AMP in single β-cells
48. Expression and functional activity of glucagon, glucagon-like peptide I, and glucose-dependent insulinotropic peptide receptors in rat pancreatic islet cells
49. Glucose intolerance but normal satiety in mice with a null mutation in the glucagon-like peptide 1 receptor gene
50. Mouse pancreatic β-cells exhibit preserved glucose competence after disruption of the glucagon-like peptide-1 receptor gene
51. Enhanced glucose-dependent insulinotropic polypeptide secretion and insulinotropic action in glucagon-like peptide 1 receptor -/- mice
52. + signaling in mouse pancreatic islets with glucagon-like peptide-1 receptor null phenotype
53. Glucose and osmosensitive neurones of the rat hypothalamus
54. Identification and characterization of glucoresponsive neurons in the enteric nervous system
55. Autonomic regulation of islet hormone secretion-implications for health and disease
56. Cell and molecular biology of the incretin hormones glucagon-like peptide-I and glucose-dependent insulin releasing polypeptide
57. Intracarotid glucose selectively increases Fos-like immunoreactivity in paraventricular, ventromedial and dorsomedial nuclei neurons
58. Hypothalamic glucose sensor: Similarities to and differences from pancreatic β-cell mechanisms
59. Analysis of upstream glucose case promoter activity in transgenic mice and identification of glucokinase of rare neuroendocrine cells in the brain and gut
60. Localization of glucokinase gene expression in the rat brain
61. Colocalization of glucagon-like peptide-1 (GLP-1) receptors, glucose transproter GLUT-2, and glucokinase mRNAs in rat hypothalamic cells: Evidence for a role of GLP-1 receptor agonists as an inhibitory signal for food and water intake
62. Functional glucokinase isoforms are expressed in rat brain
63. + fluxes and membrane potential in pancreatic β-cells
64. ATP channel conferred by a novel splice variant of SUR1
65. Histochemical and immunohistochemical localization of hexokinase isoenzymes in normal rat liver
66. Chronic hyperglycemia triggers loss of pancreatic β-cell differentiation in an animal model of diabetes
67. Dysregulation of protein synthesis in injured liver: A comparative study on microsomal and cytosole enzyme activities, microsomal lipoperoxidation and polysomal pattern in D-galactosamine and carbon tetrachloride-injured livers
68. Overexpression of monocarboxylate transporter and lactate dehydrogenase alters insulin secretory responses to pyruvate and lactate in β-cells
69. Reduced food intake and body weight in mice treated with fatty acid synthase inhibitors
70. Interplay of nutrients and hormones in the regulation of glucagon release
71. Glucose inhibition of the glucose-sensitive neurone in the rat lateral hypothalamus
72. Sensitivity of rat pancreatic A and B cells to somatostatin
73. + signaling
74. Intra-islet regulation
75. Evidence for the presence of type I insulin-like growth factor receptors on rat pancreatic A and B cells
76. Glucose-inhibition of glucagon secretion involves activation of GABAA-receptor chloride channels
77. Galanin: Sympathetic neurotransmitter in endocrine pancreas?
78. The glucose sensor protein glucokinase is expressed in glucagon-producing α-cells
79. + channel subunit Kir6.2 in mouse pancreas
80. Immuno-localization of sulphonylurea receptor 1 in rat pancreas
81. + in single beta and alpha-cells obtained from pancreatic islets by fluorescence-activated cell sorting
82. Glucose-induced intracellular ion changes in sugar-sensitive hypothalamic neurons
83. A nutrient-regulated cytosolic calcium oscillator in endocrine pancreatic glucagon-secreting cells
84. Effects of parabiosis of normal with genetically diabetic mice
85. Cephalic phase, reflex insulin secretion: Neuroanatomical and physiological characterization
86. Physiological and pathophysiological aspects of somatostatin
87. The adipoinsular axis: Effects of leptin on pancreatic beta-cells
88. Integration of NPY, AGRP, and melanocortin signals in the hypothalamic paraventricular nucleus: Evidence of a cellular basis for the adipostat
89. Biosynthesis of precursor corticotropin/endorphin-, corticotropin-, α-melanotropin-, β-lipotropin-, and β-endorphin-like material by cultured neonatal rat hypothalamic neurons
90. Hypothalamic CART is a new anorectic peptide regulated by leptin
91. Leptin differentially regulates NPY and POMC neurons projecting to the lateral hypothalamic area
92. Lateral hypothalamus and sympathetic firing rate
93. Orexins and orexin receptors: A family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior
94. Functional interactions between melanin-concentrating hormone, neuropeptide Y, and anorectic neuropeptides in the rat hypothalamus
95. Release of gastric inhibitory polypeptide from cultured canine endocrine cells
96. Regulation of intestinal proglucagon-derived peptide secretion by glucose-dependent insulinotropic peptide in a novel enteroendocrine loop
97. Regulation of glucose-dependent insulinotropic polypeptide release by protein in the rat
98. A general pattern of CNS innervation of the sympathetic outflow demonstrated by transneuronal pseudorabies viral infections
99. CNS sites involved in sympathetic and parasympathetic control of the pancreas: A viral tracing study
100. Inhibition of insulin release by norepinephrine in man
101. Galanin: A novel pancreatic neuropeptide
102. Differences in adrenergic recognition by pancreatic A and B cells
103. Effect of hypothalamic stimulation on plasma glucose, insulin, and glucagon levels
104. Glucose-induced changes in pancreatic islet blood flow mediated by central nervous system
105. The muscarinic receptor subtype in mouse pancreatic B-cells
106. Pituitary adenylate cyclase activating polypeptide is an extraordinarily potent intra-pancreatic regulator of insulin secretion from islet β-cells
107. PACAP and PACAP receptors in insulin producing tissues: Localization and effects
108. A wortmannin-sensitive signal transduction pathway is involved in the stimulation of insulin release by vasoactive intestinal polypeptide and pituitary adenylate cyclase-activating polypeptide
109. Pancreatic endocrine responses to the peptides VIP and PACAP in the conscious calf
110. Evidence that vasoactive intestinal polypeptide is a parasympathetic neurotransmitter in the endocrine pancreas in dogs
111. Human and rat β-cells differ in glucose transporter but not in glucokinase gene expression
112. Congenital leptin deficiency is associated with severe early-onset obesity in humans
113. A newly discovered role of transcription factors involved in pancreas development and the pathogenesis of diabetes mellitus
114. Sensitivity to leptin and susceptibility to seizures of mice lacking neuropeptide Y
115. Effects of neuropeptide Y deficiency on hypothalamic Agouti-related protein expression and responsiveness to melanocortin analogues
116. Expression profiling of pancreatic β-cells: Glucose regulation of secretory and metabolic pathway genes
117. cAMP-GEFII is a direct target of cAMP in regulated exocytosis